CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers (Q39421433)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers |
scientific article |
Statements
1 reference
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers (English)
1 reference
Rodolfo Machiorlatti
1 reference
Bruce A Ruggeri
1 reference
Mangeng Cheng
1 reference
Matthew R Quail
1 reference
Diane E Gingrich
1 reference
Gregory R Ott
1 reference
Lihui Lu
1 reference
Weihua Wan
1 reference
Mark S Albom
1 reference
Thelma S Angeles
1 reference
Lisa D Aimone
1 reference
Flavio Cristofani
1 reference
Cristina Abele
1 reference
Mark A Ator
1 reference
Bruce D Dorsey
1 reference
Giorgio Inghirami
1 reference
27 December 2011
1 reference
1 reference
11
1 reference
3
1 reference
670-679
1 reference
1 reference
Identifiers
1 reference
1 reference